mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.2 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.2 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |